Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aurobindo Pharma Ltd. Investor Presentation 2018

Aug 24, 2018

61251_rns_2018-08-24_8e7919be-c54d-4b21-8fde-dfc0da909745.pdf

Investor Presentation

Open in viewer

Opens in your device viewer

August 24, 2018

ToListing Department,NATIONAL STOCK EXCHANGE OF INDIA LIMITEDExchange Plaza,Bandra Kurla Complex, Bandra (E),MUMBAI -400 051Company Code No. AUROPHARMA ToThe Corporate Relations DepartmentBSE LIMITEDPhiroz Jeejeebhoy Towers,25thfloor, Dalal Street,MUMBAI -400 001Company Code No. 524804

Dear Sirs,

Sub: Analysts / Investors Meet.

We would like to inform you that we are attending investor conference hosted by Motilal Oswal on 27[th] August, 2018 in Mumbai. We will be using the presentation which we have shared with your exchange on 20[th] August, 2018 and also uploaded on the website of the Company in the following weblink.

http://www.aurobindo.com/investor-relations/investors/investor-presentation

Please take the information on record.

Thanking you,

Yours faithfully, For AUROBINDO PHARMA LIMITED

==> picture [74 x 19] intentionally omitted <==

B. Adi Reddy Company Secretary